NCT03544619

Brief Summary

In this study, investigators want to perform the reliability and cross-cultural Adaptation of the Turkish Version of the Neuropathic Pain Symptom Inventory

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 21, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 4, 2018

Completed
6 days until next milestone

Study Start

First participant enrolled

June 10, 2018

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 25, 2020

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
Last Updated

May 13, 2020

Status Verified

May 1, 2020

Enrollment Period

2.5 years

First QC Date

May 21, 2018

Last Update Submit

May 11, 2020

Conditions

Neuropathic Pain

Outcome Measures

Primary Outcomes (2)

  • Reliability and adaptation

    Investigators will use linguistic validaiton guideline of Mapi research.

    7 weeks

  • DN4

    DN4 has become one of the principal condition-specific outcome measures of neuropathic pain.Investigators will use it for comparing results of NPSI.

    5 minutes

Interventions

Neuropathic Pain Symptom InventoryOTHER

Investigators will use the Neuropathic Pain Symptom Inventory for assessing neuropathic symptoms

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who have neuropathic symptoms

You may qualify if:

  • Age upper 18
  • Complaints of neuropathic pain for at least 3 months

You may not qualify if:

  • Presence of psychiatric illness
  • Cancer pain, unsuccessful lumbar surgeon syndrome etc. mix type pain presence
  • Presence of complex regional pain syndrome
  • Cognitive impairment (mini-mental test score \<24)
  • Native language is not Turkish

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erenkoy Physical Treatment Nad Rehabilitation Hospital

Istanbul, 34400, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Neuralgia

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • unsal sarı

    ERENKOY PHYSICAL THERAPY AND REHABILITATION HOSPITAL

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical doctor, specialist on physical therapy and rehabilitation

Study Record Dates

First Submitted

May 21, 2018

First Posted

June 4, 2018

Study Start

June 10, 2018

Primary Completion

December 25, 2020

Study Completion

December 30, 2020

Last Updated

May 13, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations

TU(1)